BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells-Reference-Cited by-同舟云学术

BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells

Published:2015-05-06 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Baker Emma K,Taylor Scott,Gupte Ankita,Sharp Phillip P,Walia Mannu,Walsh Nicole C,Zannettino Andrew CW,Chalk Alistair M,Burns Christopher J,Walkley Carl R

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep10120.pdf

Reference58 articles.

1. Bacci, G. et al. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur. J. Cancer 41, 2836–2845 (2005).

2. Allison, D. C. et al. A meta-analysis of osteosarcoma outcomes in the modern medical era. Sarcoma 2012, 704872 (2012).

3. Kaste, S. C., Pratt, C. B., Cain, A. M., Jones-Wallace, D. J. & Rao, B. N. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer 86, 1602–1608 (1999).

4. Janeway, K. A. & Grier, H. E. Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol 11, 670–678 (2010).

5. Birch, J. M. et al. Relative frequency and morphology of cancers in carriers of germline TP53 mutations. Oncogene 20, 4621–4628 (2001).

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bromodomain inhibitor treatment leads to overexpression of multiple kinases in cancer cells;Neoplasia;2024-11

2. EP-0108A is a moderation selectively BRD4 BD2 inhibitor with potential AML tumor suppression;Anti-Cancer Drugs;2024-08-28

3. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc;Proceedings of the National Academy of Sciences;2024-04-24

4. Investigation of the impact of bromodomain inhibition on cytoskeleton stability and contraction;Cell Communication and Signaling;2024-03-16

5. The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signaling;Experimental Hematology & Oncology;2024-03-04